Zentek (NASDAQ:ZTEK) Given Sell (E+) Rating at Weiss Ratings

Key Points

• Zentek's stock has been given a "sell (e+)" rating by Weiss Ratings, which was reaffirmed in a recent investor note.
• The company's stock price increased by 0.9% to $0.81 during recent trading, despite having a market capitalization of approximately $85.16 million.
• Zentek reported a negative net margin of 981.17% and a revenue of only $0.04 million for the last quarter, indicating significant financial challenges.

Zentek (NASDAQ:ZTEK - Get Free Report)'s stock had its "sell (e+)" rating reaffirmed by research analysts at Weiss Ratings in a note issued to investors on Friday,Weiss Ratings reports.

Zentek Stock Up 0.9%

NASDAQ ZTEK traded up $0.01 during trading on Friday, hitting $0.81. The stock had a trading volume of 39,066 shares, compared to its average volume of 132,205. The company has a market capitalization of $85.16 million, a PE ratio of -16.24 and a beta of 0.90. The company's 50-day moving average price is $0.81 and its two-hundred day moving average price is $1.09. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.30 and a current ratio of 1.62. Zentek has a 12 month low of $0.62 and a 12 month high of $1.84.

Zentek (NASDAQ:ZTEK - Get Free Report) last released its earnings results on Thursday, August 14th. The company reported ($0.01) EPS for the quarter. Zentek had a negative net margin of 981.17% and a negative return on equity of 55.41%. The firm had revenue of $0.04 million during the quarter.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.